Evidence map›Paper›PMID 28604677›Full record

ArticleNature cell biology2017

Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.

Urs Graf, Elisa A Casanova, Sarah Wyck, Damian Dalcher, Marco Gatti, Eva Vollenweider, Michal J Okoniewski, Fabienne A Weber, Sameera S Patel, Marc W Schmid and 9 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Identification ofGenes · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 3 countries.

Urs GrafDepartment of Trauma Surgery, Center for Clinical Research, University Hospital Zurich, University of Zurich, Sternwartstrasse 14, CH-8091 Zurich, Switzerland.
Elisa A CasanovaDepartment of Trauma Surgery, Center for Clinical Research, University Hospital Zurich, University of Zurich, Sternwartstrasse 14, CH-8091 Zurich, Switzerland.
Sarah WyckLife Science Zurich Graduate School, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Damian DalcherLife Science Zurich Graduate School, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Marco GattiInstitute of Molecular Cancer Research, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Eva VollenweiderLife Science Zurich Graduate School, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Michal J OkoniewskiScientific IT Services, ETH Zurich, Weinbergstrasse 11, CH-8092 Zurich, Switzerland.
Fabienne A WeberInstitute of Laboratory Animal Science, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Sameera S PatelInstitute of Laboratory Animal Science, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Marc W SchmidService and Support for Science IT, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Jiwen LiShanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China.
Jafar SharifDevelopmental Genetics Laboratory, RIKEN Center for Integrative Medical Sciences, 1-7-22 Suehiuro-cho, Tsurumi-ku, Yokohama City, Kanagawa 230-0045, Japan.
Guido A WannerDepartment of Trauma Surgery, Center for Clinical Research, University Hospital Zurich, University of Zurich, Sternwartstrasse 14, CH-8091 Zurich, Switzerland.
Haruhiko KosekiDevelopmental Genetics Laboratory, RIKEN Center for Integrative Medical Sciences, 1-7-22 Suehiuro-cho, Tsurumi-ku, Yokohama City, Kanagawa 230-0045, Japan.
Jiemin WongShanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China.
Pawel PelczarCenter for Transgenic Models, University of Basel, Mattenstrasse 22, CH-4002 Basel, Switzerland.
Lorenza PenengoInstitute of Molecular Cancer Research, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Raffaella SantoroDepartment of Molecular Mechanisms of Disease, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Paolo CinelliDepartment of Trauma Surgery, Center for Clinical Research, University Hospital Zurich, University of Zurich, Sternwartstrasse 14, CH-8091 Zurich, Switzerland.
University of Zurich · CHLife Science Zurich · CHUniversity Hospital of Zurich · CHEast China Normal University · CNRIKEN Center for Integrative Medical Sciences · JPETH Zurich · CHUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Naive pluripotency is established in preimplantation epiblast. Embryonic stem cells (ESCs) represent the immortalization of naive pluripotency. 2i culture has optimized this state, leading to a gene signature and DNA hypomethylation closely comparable to preimplantation epiblast, the developmental ground state. Here we show that Pramel7 (PRAME-like 7), a protein highly expressed in the inner cell mass (ICM) but expressed at low levels in ESCs, targets for proteasomal degradation UHRF1, a key factor for DNA methylation maintenance. Increasing Pramel7 expression in serum-cultured ESCs promotes a preimplantation epiblast-like gene signature, reduces UHRF1 levels and causes global DNA hypomethylation. Pramel7 is required for blastocyst formation and its forced expression locks ESCs in pluripotency. Pramel7/UHRF1 expression is mutually exclusive in ICMs whereas Pramel7-knockout embryos express high levels of UHRF1. Our data reveal an as-yet-unappreciated dynamic nature of DNA methylation through proteasome pathways and offer insights that might help to improve ESC culture to reproduce in vitro the in vivo ground-state pluripotency.

Indexed as

Epigenesis, GeneticAnimalsAntigens, NeoplasmBlastocystCCAAT-Enhancer-Binding ProteinsCullin ProteinsDNA MethylationEmbryonic Stem CellsGene Expression Regulation, DevelopmentalHEK293 CellsHumansMice, Inbred C57BLNeoplasm ProteinsNuclear ProteinsPhenotypePluripotent Stem CellsAntigens, NeoplasmATP dependent 26S proteaseCCAAT-Enhancer-Binding ProteinsCUL2 protein, humanCullin ProteinsNeoplasm ProteinsNuclear ProteinsPramel7 protein, mouseProteasome Endopeptidase ComplexUbiquitin-Protein LigasesUhrf1 protein, mouse

Identifiers

PMID28604677
OpenAlexW2625568097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.